DE69103934D1 - 4H-Pyrrolo[1,2-a]thieno[3,2-f][1,4]diazepinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen. - Google Patents

4H-Pyrrolo[1,2-a]thieno[3,2-f][1,4]diazepinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.

Info

Publication number
DE69103934D1
DE69103934D1 DE69103934T DE69103934T DE69103934D1 DE 69103934 D1 DE69103934 D1 DE 69103934D1 DE 69103934 T DE69103934 T DE 69103934T DE 69103934 T DE69103934 T DE 69103934T DE 69103934 D1 DE69103934 D1 DE 69103934D1
Authority
DE
Germany
Prior art keywords
thieno
pyrrolo
processes
preparation
pharmaceutical preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69103934T
Other languages
English (en)
Other versions
DE69103934T2 (de
Inventor
Sylvain Rault
Michel Boulouard
Patrick Dallemagne
Max Robba
Beatrice Guardiola
Michelle Devissaguet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Application granted granted Critical
Publication of DE69103934D1 publication Critical patent/DE69103934D1/de
Publication of DE69103934T2 publication Critical patent/DE69103934T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69103934T 1990-03-08 1991-03-07 4H-Pyrrolo[1,2-a]thieno[3,2-f][1,4]diazepinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen. Expired - Fee Related DE69103934T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9002933A FR2659331A1 (fr) 1990-03-08 1990-03-08 Nouveaux derives de la 4h-pyrrolo [1,2-a] thieno [3,2-f] [1,4]-diazepine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Publications (2)

Publication Number Publication Date
DE69103934D1 true DE69103934D1 (de) 1994-10-20
DE69103934T2 DE69103934T2 (de) 1995-04-20

Family

ID=9394511

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69103934T Expired - Fee Related DE69103934T2 (de) 1990-03-08 1991-03-07 4H-Pyrrolo[1,2-a]thieno[3,2-f][1,4]diazepinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.

Country Status (14)

Country Link
US (1) US5190939A (de)
EP (1) EP0446133B1 (de)
JP (1) JPH04234889A (de)
AT (1) ATE111467T1 (de)
AU (1) AU632906B2 (de)
CA (1) CA2037654A1 (de)
DE (1) DE69103934T2 (de)
ES (1) ES2064054T3 (de)
FR (1) FR2659331A1 (de)
IE (1) IE910769A1 (de)
NZ (1) NZ237365A (de)
OA (1) OA09486A (de)
PT (1) PT96964A (de)
ZA (1) ZA911727B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660310B1 (fr) * 1990-03-27 1992-06-05 Adir Nouveaux derives de la 4h-pyrrolo[1,2a] thieno[2,3-f] diazepine[1,4], leur procede de preparation et les compositions pharmaceutiques les renfermant.
WO1995032963A1 (fr) * 1994-06-01 1995-12-07 Yoshitomi Pharmaceutical Industries, Ltd. Compose de thienylazole et compose de thienotriazolodiazepine
HU214588B (hu) * 1994-07-01 1998-04-28 EGIS Gyógyszergyár Rt. Eljárás bicikloheptán-származékot tartalmazó, CCK-rendszer gátló hatású gyógyászati készítmények előállítására

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1332410C (en) * 1984-06-26 1994-10-11 Roger M. Freidinger Benzodiazepine analogs
EP0368175A1 (de) * 1988-11-06 1990-05-16 Boehringer Ingelheim Kg 3S,7S-3-(Morpholinocarbonyl)-5-(2-chlorphenyl)-7,10-dimethyl-3,4-dihydro-2H,7H-cyclopenta[4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin.

Also Published As

Publication number Publication date
OA09486A (fr) 1992-11-15
AU7271091A (en) 1991-09-12
IE910769A1 (en) 1991-09-11
US5190939A (en) 1993-03-02
EP0446133B1 (de) 1994-09-14
AU632906B2 (en) 1993-01-14
ZA911727B (en) 1991-12-24
ES2064054T3 (es) 1995-01-16
PT96964A (pt) 1991-10-31
FR2659331A1 (fr) 1991-09-13
DE69103934T2 (de) 1995-04-20
JPH04234889A (ja) 1992-08-24
EP0446133A1 (de) 1991-09-11
NZ237365A (en) 1991-12-23
CA2037654A1 (fr) 1991-09-09
ATE111467T1 (de) 1994-09-15

Similar Documents

Publication Publication Date Title
DE69131813T2 (de) Amido-3-Pyrazol-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
DE69110625D1 (de) Oxazolopyridinderivate, Verfahren zu ihrer Herstellung und die sie enthaltenden pharmazeutischen Zusammensetzungen.
DE69634806D1 (de) Substituierte heterocyclische Verbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
EP1070710A3 (de) Dithiolan Derivate, deren Herstellung und deren therapeutischer Wirkung
DE59611204D1 (de) Arylglycinamidderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
DE69130412D1 (de) Pyrazolopyridinverbindung und Verfahren zu ihrer Herstellung
HUP0003826A2 (hu) Új triazolo [4,5-d] pirimidin-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
DE69508667T2 (de) Benzothiadiazinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE69028602D1 (de) Pyridazin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE69027286D1 (de) Cephalosporin-Derivate, Verfahren zu ihrer Herstellung und diese Derivate enthaltende antimikrobielle Zusammensetzung
AP9801377A0 (en) Tricyclic erythromycin derivatives.
DE69406853T2 (de) Alpha Aminosäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
ATE104278T1 (de) N-substituierte alpha-mercaptoalkylaminderivate, verfahren zu ihrer herstellung und hergestellte zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende zusammensetzungen.
IL112102A0 (en) Annelated dihydropyridinoacetic acid derivatives, their preparation and pharmaceutical compositions containing them
DE69321861D1 (de) 3-Aminochroman-Spiroderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE69103934D1 (de) 4H-Pyrrolo[1,2-a]thieno[3,2-f][1,4]diazepinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DE69310052D1 (de) Kardioaktive 17B-(3-Furyl) und 17B-(4-Pyridazinyl)-5beta, 14beta-Androstan Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon
TW252979B (de)
DE69211637D1 (de) Neue dna-gyrase inhibitoren, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE58909594D1 (de) 6-Oxo-pyridazinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
ATE14437T1 (de) Aminoglycosid-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und solche derivate zur verwendung als arzneimittel.
DE69512419T2 (de) IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-2-CARBONSÄURE DERIVATE, IHRE HERSTELLUNG UND SIE ENTHALTENDE ARZNEIMITTEL
DE69127880D1 (de) Pyrrolo[2,3-d]azepinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
ATE267163T1 (de) Tricyclische verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DE69129114T2 (de) Azabicyclische verbindungen, verfahren und zwischenprodukte zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee